Clearmind Medicine Granted Patent Approval for Psychedelic-Based Alcohol Substitute in India
June 1, 2022
Ryan Allway June 1st, 2022 Psychedelics, Top News The patent was granted by India’s Office of the Controller-General of Patents, Designs and Trademarks VANCOUVER, June 1, 2022– Clearmind Medicine Inc. (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) (“Clearmind” or the “Company“), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics... Read more
Clearmind Medicine to Host ‘Psychedelics for Alcoholism‘ Virtual Educational Event on October 20
October 1, 2021
Ryan Allway October 1st, 2021 Psychedelics An expert panel will present and discuss new potential treatments for Alcohol Use Disorder and binge drinking TORONTO, Oct. 01, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Clearmind Medicine Inc. (CSE: CMND) (“Clearmind” or the “Company“), a psychedelic medicine biotech company focused on... Read more
